Stay updated on Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe clinical trial record for tisotumab vedotin in platinum-resistant ovarian cancer is available again, with study details, participant criteria, outcomes, locations, and supporting documents.SummaryDifference78%

- Check20 days agoChange DetectedThe footer revision label was updated from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe footer now identifies ClinicalTrials.gov as revision v3.7.2 instead of v3.7.1, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page remains an access-denied error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study record page now shows a 403 Forbidden error, preventing access to the study details and page content.SummaryDifference0.5%

Stay in the know with updates to Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.